VivoSeq
Other

Gastrointestinal Bleeding

0

Pipeline Programs

4

Active Trials

0

Companies Involved

GastroIntestinal Bleeding is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

63/100

Attrition Rate

17/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

12

clinical trials

Completed5 · 42%
Not yet recruiting2 · 17%
Recruiting2 · 17%
Withdrawn1 · 8%
Suspended1 · 8%
Terminated1 · 8%

Trial Activity

12 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)